Uncategorized Phage therapy in IBD 13 Sep 2022 MICROBIOMES Phage therapy suppresses gut inflammation in IBD The gut microbiota is known to contribute to the pathology of inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis. But…
Uncategorized TAILOR achieves clinical success with phage therapy 9 Sep 2022 A patient in a hospital develops an antibiotic-resistant bacterial infection that is untreatable or only treatable with the most toxic of antibiotics. During the 48 hours it takes to identify…
Uncategorized Using Nanoantibiotics to Counter Antibiotic Resistance Gains US Patent 4 Sep 2022 Over 2.8 million Americans get antibiotic-resistant bacterial infections anually, and about 35,000 of those patients do not make it through their infection, according to the Centers for Disease Control and…
Uncategorized The past, present, and future of antibiotics 4 Sep 2022 Read this great article by Cook et al. at https://www.science.org/doi/10.1126/scitranslmed.abo7793 Abstract Antibiotics have transformed modern medicine. They are essential for treating infectious diseases and enable vital therapies and procedures. However,…
Uncategorized Celebrating Ryland Young’s career, advances in phage applications 2 Sep 2022 After Ryland ‘Ry’ Young retires on Aug. 31, his students can keep an ear out for his signature jangling of keys in the hallways — the renowned faculty member will…
Uncategorized How an army of ‘friendly viruses’ fighting a war on superbugs 29 Aug 2022 They are ruthlessly efficient killers, with six spider-like ‘legs’ they use to latch on to their prey, and bulbous heads with 20 faces. When they attack in swarms, they are…
Uncategorized Phage Therapy Starts Realizing Its Long-Deferred Potential 21 Aug 2022 Soon after bacteria-killing viruses were independently discovered by English physician Frederick Twort in 1915 and by French microbiologist Felix d’Herelle in 1917, the tiny microbes were seen to have therapeutic…
Uncategorized New Results! Out Now! read… 19 Aug 2022 Phage-antibiotic combinations to control Pseudomonas aeruginosa-Candida two-species biofilms Authored by Prasanth Manohar, Belinda Loh, Ramesh Nachimuthu, Sebastian Leptihn Abstract Phage-antibiotic combinations to treat bacterial infections are gaining increased attention due to the synergistic effects often observed…
Uncategorized Out Now! Publication alert 15 Aug 2022 A Lysozyme Murein Hydrolase with Broad-Spectrum Antibacterial Activity from Enterobacter Phage myPSH1140 Nachimuthu Ramesh, Prasanth Manohar, Kandasamy Eniyan, Loganathan Archana, Sudarsanan Athira, Belinda Loh, Long Ma, Sebastian Leptihn https://journals.asm.org/doi/epub/10.1128/aac.00506-22 ABSTRACT Bacteriophages and bacteriophage-derived peptidoglycan hydrolases (endolysins) present promising alternatives for the treatment of infections caused by multidrug…
Uncategorized Targeted suppression of human IBD…phage consortia 5 Aug 2022 Targeted suppression of human IBD-associated gut microbiota commensals by phage consortiafor treatment of intestinal inflammation Very interesting work!!! https://doi.org/10.1016/j.cell.2022.07.003 SUMMARY Human gut commensals are increasingly suggested to impact non-communicable diseases,…